Prostate Cancer - Results from #120

Clinical impact of ERG and PTEN status in prostate cancer patients underwent radical prostatectomy. December 30, 2022

Nomograms predict survival benefits of radical prostatectomy and chemotherapy for prostate cancer with bone metastases: A SEER-based study. December 30, 2022

18F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer. December 30, 2022

A pilot study of MRI radiomics for high-risk prostate cancer stratification in 1.5 T MR-guided radiotherapy. December 29, 2022

Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR® system. December 29, 2022

Conditional gene regulation models demonstrate a pro-proliferative role for growth hormone receptor in prostate cancer. December 29, 2022

Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations. December 29, 2022

Exome sequencing of affected duos and trios uncovers PRUNE2 as a novel prostate cancer predisposition gene. December 29, 2022

A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer. December 28, 2022

Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA. December 28, 2022

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer. December 28, 2022

Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry. December 28, 2022

Performance of multiparametric prostate magnetic resonance imaging validated by targeted and systematic transperineal biopsies. December 28, 2022

Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial. December 28, 2022

Long Term Results of a Phase III Randomized Prospective Trial of Erectile Tissue Sparing IMRT for Men with Clinically Localized Prostate Cancer. December 27, 2022

Prognostic Impact and Clinical Implications of Unfavorable Upgrading in Low-Risk Prostate Cancer after Robot-Assisted Radical Prostatectomy: Results of a Single Tertiary Referral Center. December 27, 2022

IL-1β expression driven by androgen receptor absence or inactivation promotes prostate cancer bone metastasis. December 27, 2022

Mindfulness-based stress reduction for men on active surveillance for prostate cancer and their spouses: Design and methodology of a randomized controlled trial. December 27, 2022

Distant Nodes Seen on PSMA PET-CT Staging Predicts Post-Treatment Progression in Men with Newly Diagnosed Prostate Cancer-A Prospective Cohort Study. December 27, 2022

Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new concepts. December 26, 2022

Page 7 of 1275

email news signup